Your browser doesn't support javascript.
loading
Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
Taira, Naruto; Kashiwabara, Kosuke; Tsurutani, Junji; Kitada, Masahiro; Takahashi, Masato; Kato, Hiroaki; Kikawa, Yuichiro; Sakata, Eiko; Naito, Yoichi; Hasegawa, Yoshie; Saito, Tsuyoshi; Iwasa, Tsutomu; Takashima, Tsutomu; Aihara, Tomohiko; Mukai, Hirofumi; Hara, Fumikata.
Afiliación
  • Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. ntaira@md.okayama-u.ac.jp.
  • Kashiwabara K; Clinical Research Promotion Center, University of Tokyo Hospital, Tokyo, Japan.
  • Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
  • Kitada M; Breast Disease Center, Asahikawa Medical University Hospital, Hokkaido, Japan.
  • Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.
  • Kato H; Department of Breast Surgery, Teine Keijinkai Hospital, Hokkaido, Japan.
  • Kikawa Y; Department of Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.
  • Sakata E; Department of Breast Surgery, Niigata City General Hospital, Niigata, Japan.
  • Naito Y; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Aomori, Japan.
  • Saito T; Department of Breast Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
  • Iwasa T; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Aihara T; Breast Center, Aihara Hospital, Osaka, Japan.
  • Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Hara F; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Breast Cancer ; 29(1): 186-188, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34562260
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón